Design of a comprehensive Alzheimer's disease clinic and research center in Spain to meet critical patient and family needs

Alzheimer's disease (AD) affects people worldwide, and the prevalence is increasing as the population ages. There is an international effort to understand the biology of AD to develop primary and secondary prevention strategies, and to develop effective therapeutic interventions for individuals who are already symptomatic. One of the critically important pieces of all national plans to address AD is the call for the development of service models to deliver quality, effective care based on the best evidence available.

• Publication year

  2013

• Venue

  Alzheimer's & Dementia

• Publication date

  2013-09-12

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jalz.2013.03.006PMID 24035148PMCID PMC3951687
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• P1‐071: Intensity of dementia through latent variable modelling (I‐DeLV) in the AIBL cohort

  2012cited by this paper
• Normative data of a brief neuropsychological battery for Spanish individuals older than 49

  2012cited by this paper
• Estrogen receptor alpha gene variants are associated with Alzheimer's disease.

  2012cited by this paper
• Clinical diagnosis of Alzheimer's disease: Report of the NINCDS—ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

  2011cited by this paper
• Genetic association of complement receptor 1 polymorphism rs3818361 in Alzheimer's disease

  2011cited by this paper
• The membrane-spanning 4-domains, subfamily A (MS4A) gene cluster contains a common variant associated with Alzheimer's disease

  2011cited by this paper
• The MTHFD1L Gene rs11754661 Marker is Not Associated with Alzheimer's Disease in a Sample of the Spanish Population

  2011cited by this paper
• Genome-wide analysis of genetic loci associated with Alzheimer disease.

  2010cited by this paper
• Genetic screening of Alzheimer's disease genes in Iberian and African samples yields novel mutations in presenilins and APP.

  2010cited by this paper
• CALHM1 P86L Polymorphism is Associated with Late-Onset Alzheimer's Disease in a Recessive Model

  2010cited by this paper
• The CALHM1 P86L Polymorphism is a Genetic Modifier of Age at Onset in Alzheimer's Disease: a Meta-Analysis Study

  2010cited by this paper
• Design of comprehensive Alzheimer's disease centers to address unmet national needs

  2010influential reference
• Detection of visuoperceptual deficits in preclinical and mild Alzheimer's disease

  2009cited by this paper
• GOLPH2 Gene Markers are Not Associated with Alzheimer's Disease in a Sample of the Spanish Population

  2009cited by this paper
• A clinical registry of dementia based on the principle of epidemiological surveillance

  2009cited by this paper
• GAB2 gene does not modify the risk of Alzheimer's disease in Spanish APOE 4 carriers

  2009cited by this paper
• Cardiorespiratory fitness and brain atrophy in early Alzheimer disease

  2008cited by this paper
• Clinical diagnostic criteria for dementia associated with Parkinson's disease

  2007cited by this paper
• Mild cognitive impairment

  2006cited by this paper
• [A proposal for a clinical registry of dementias].

  2006cited by this paper
• Propuesta para un registro clínico de demencias

  2006cited by this paper
• Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium

  2005cited by this paper
• Diagnosis and management of dementia with Lewy bodies

  2005cited by this paper
• Neuropsychological characteristics of mild cognitive impairment subgroups

  2005cited by this paper
• Mild cognitive impairment as a diagnostic entity

  2004cited by this paper
• Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment

  2004cited by this paper
• Operational Definitions for the NINDS-AIREN Criteria for Vascular Dementia: An Interobserver Study

  2003cited by this paper
• Mild Cognitive Impairment Clinical Characterization and Outcome

  1999cited by this paper
• Frontotemporal lobar degeneration

  1998cited by this paper
• DSM-IV: Diagnostic and Statistical Manual of Mental Disorders

  1994cited by this paper
• Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups.

  1994cited by this paper
• Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers

  1992cited by this paper
• Clinical diagnosis of Alzheimer's disease

  1984cited by this paper
• 1 The GloBAl eCoNomiC impACT oF demeNTiA Alzheimer ’ s diseAse internAtionAl World Alzheimer report 2010 the GlobAl economic impAct of dementiA

  year unknowncited by this paper
• Alzheimer ’ s disease facts and figures Alzheimer ’ s Association

  year unknowncited by this paper

• The COMFORTage project: study protocol for the integration of multiple sources towards personalised preventions at Ace Alzheimer Center Barcelona

  2026cites this paper
• Plasma proteomic signatures associate with near-future Alzheimer’s disease dementia conversion in mild cognitive impairment patients

  2026cites this paper
• Federated learning for cognitive impairment detection using speech data

  2025cites this paper
• Cerebrospinal fluid biomarkers of Alzheimer's disease in Lewy body diseases: The performance of fully automated immunoassays

  2025cites this paper
• GWAS meta-analysis of CSF Alzheimer's disease biomarkers 18,948 individuals reveal novel loci and genes regulating lipid metabolism, brain volume and autophagy

  2025cites this paper
• APOE Haplotype Phasing Using ONT Long-Read Sequencing Reveals Two Common ε3 and ε4 intragenic haplotypes in the Spanish Population

  2025cites this paper
• Exploring sex differences in Alzheimer’s disease: a comprehensive analysis of a large patient cohort from a memory unit

  2025cites this paper
• Genetic dissection of hippocampal sclerosis of ageing using magnetic resonance imaging surrogates

  2025cites this paper
• A peripheral proteomic signature of Alzheimer’s disease is identified in the plasma extracellular vesicles of mild cognitive impairment patients from a memory clinic: the BIOPEXAL study

  2025cites this paper
• Unveiling the sound of the cognitive status: Machine Learning-based speech analysis in the Alzheimer’s disease spectrum

  2024cites this paper
• Head-to-Head Comparison of Aptamer- and Antibody-Based Proteomic Platforms in Human Cerebrospinal Fluid Samples from a Real-World Memory Clinic Cohort

  2024cites this paper
• Changes in choroidal thickness quantified by Optical Coherence Tomography across cognitive impairment: data from the NORFACE cohort

  2024cites this paper
• Clinical value of plasma pTau181 to predict Alzheimer's disease pathology in a large real-world cohort of a memory clinic

  2024cites this paper
• Association of oxidative stress and inflammatory metabolites with Alzheimer’s disease cerebrospinal fluid biomarkers in mild cognitive impairment

  2024cites this paper
• Head-to-head comparison of aptamer- and antibody-based proteomic platforms in human cerebrospinal fluid samples from a real-world memory clinic cohort

  2024cites this paper
• Genome-wide association study and polygenic risk scores of retinal thickness across the cognitive continuum: data from the NORFACE cohort

  2024cites this paper
• Different inflammatory signatures based on CSF biomarkers relate to preserved or diminished brain structure and cognition

  2024cites this paper
• The Synergic Effect of AT(N) Profiles and Depression on the Risk of Conversion to Dementia in Patients with Mild Cognitive Impairment

  2023cites this paper
• Harnessing acoustic speech parameters to decipher amyloid status in individuals with mild cognitive impairment

  2023cites this paper
• Profiling Individuals with Dementia Using Cluster Analysis

  2023cites this paper
• Macular vessel density in the superficial plexus is not associated to cerebrospinal fluid core biomarkers for Alzheimer’s disease in individuals with mild cognitive impairment: The NORFACE cohort

  2023cites this paper
• Correlations between the NMR Lipoprotein Profile, APOE Genotype, and Cholesterol Efflux Capacity of Fasting Plasma from Cognitively Healthy Elderly Adults

  2023cites this paper
• Mendelian Randomisation Confirms the Role of Y-Chromosome Loss in Alzheimer’s Disease Aetiopathogenesis in Men

  2023cites this paper
• Differences in macular vessel density in the superficial plexus across cognitive impairment: the NORFACE cohort

  2022cites this paper
• Establishing In-House Cutoffs of CSF Alzheimer’s Disease Biomarkers for the AT(N) Stratification of the Alzheimer Center Barcelona Cohort

  2022cites this paper
• The role of sex and gender in the selection of Alzheimer patients for clinical trial pre-screening

  2021cites this paper
• Neuropsychiatric profiles and conversion to dementia in mild cognitive impairment, a latent class analysis

  2021cites this paper
• From Face-to-Face to Home-to-Home: Validity of a Teleneuropsychological Battery

  2021cites this paper
• Memory care approaches to better leverage capacity of dementia specialists: a narrative synthesis.

  2021cites this paper
• Combination of white matter hyperintensities and Aβ burden is related to cognitive composites domain scores in subjective cognitive decline: the FACEHBI cohort

  2021cites this paper
• BIOFACE: A Prospective Study of Risk Factors, Cognition, and Biomarkers in a Cohort of Individuals with Early-Onset Mild Cognitive Impairment. Study Rationale and Research Protocols

  2021cites this paper
• Quercetin stimulates the non-amyloidogenic pathway via activation of ADAM10 and ADAM17 gene expression in aluminum chloride-induced Alzheimer's disease rat model.

  2021cites this paper
• Sex and gender considerations in clinical trials for Alzheimer’s disease: Current state and recommendations

  2021cites this paper
• The Relationship of APOE ε4, Race, and Sex on the Age of Onset and Risk of Dementia

  2021cites this paper
• Neuropsychiatric Profile as a Predictor of Cognitive Decline in Mild Cognitive Impairment

  2021cites this paper
• Soluble TAM receptors sAXL and sTyro3 predict structural and functional protection in Alzheimer's disease.

  2021cites this paper
• Interaction of neuropsychiatric symptoms with APOE ε4 and conversion to dementia in MCI patients in a Memory Clinic

  2020cites this paper
• Association between retinal thickness and β-amyloid brain accumulation in individuals with subjective cognitive decline: Fundació ACE Healthy Brain Initiative

  2020cites this paper
• A Deep Neural Network Classification Approach for Alzheimer’s Disease Diagnosis

  2020cites this paper
• Interaction of neuropsychiatric symptoms with APOE ε4 and conversion to dementia in MCI patients in a Memory Clinic

  2020cites this paper
• Dementia Care in Times of COVID-19: Experience at Fundació ACE in Barcelona, Spain

  2020cites this paper
• Association of lysophosphatidic acids with cerebrospinal fluid biomarkers and progression to Alzheimer’s disease

  2020cites this paper
• Evaluation of macular thickness and volume tested by optical coherence tomography as biomarkers for Alzheimer’s disease in a memory clinic

  2020cites this paper
• A computerized version of the Short Form of the Face-Name Associative Memory Exam (FACEmemory®) for the early detection of Alzheimer’s disease

  2020cites this paper
• Managing Clinical Trials for Alzheimer’s Disease During the COVID-19 Crisis: Experience at Fundació ACE in Barcelona, Spain

  2020cites this paper
• Genome‐wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks: The GR@ACE project

  2019cites this paper
• Visual impairment in aging and cognitive decline: experience in a Memory Clinic

  2019cites this paper
• Genome-wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer’s disease and three causality networks of AD: the GR@ACE project

  2019cites this paper
• Comparative Cognitive Effects of Choreographed Exercise and Multimodal Physical Therapy in Older Adults with Amnestic Mild Cognitive Impairment: Randomized Clinical Trial

  2019cites this paper
• Plasma Aβ42/40 ratio alone or combined with FDG-PET can accurately predict amyloid-PET positivity: a cross-sectional analysis from the AB255 Study

  2019cites this paper
• Usefulness of peripapillary nerve fiber layer thickness assessed by optical coherence tomography as a biomarker for Alzheimer’s disease

  2018cites this paper
• Scientific Autobiography: On Brain Health and Cognitive Fitness Into the Later Years of Life-Journey of a Behavioral Neurologist of Aging.

  2018cites this paper
• The Spanish version of Face-Name Associative Memory Exam (S-FNAME) performance is related to amyloid burden in Subjective Cognitive Decline

  2018cites this paper
• The Role of Verb Fluency in the Detection of Early Cognitive Impairment in Alzheimer’s Disease

  2018cites this paper
• Patient Engagement: The Fundació ACE Framework for Improving Recruitment and Retention in Alzheimer’s Disease Research

  2018influential citation
• The role of verb fluency in the detection of early cognitive impairment in Alzheimer ' s disease

  2018cites this paper
• The role of verb fluency in the detection of early cognitive impairment in Alzheimer's disease

  2018cites this paper
• The role of verb fluency in the detection of early cognitive impairment in Alzheimer's disease

  2018cites this paper
• Dementia Diagnostic Services for Ireland: a literature review

  2018cites this paper
• Exploring Genetic Associations of Alzheimer’s Disease Loci With Mild Cognitive Impairment Neurocognitive Endophenotypes

  2018cites this paper
• Data Mining Approaches for Alzheimer's Disease Diagnosis

  2017cites this paper
• Impact of Recruitment Methods in Subjective Cognitive Decline

  2017cites this paper
• Cognitive Composites Domain Scores Related to Neuroimaging Biomarkers within Probable-Amnestic Mild Cognitive Impairment-Storage Subtype

  2017influential citation
• Effect of the oral administration of nanoencapsulated quercetin on a mouse model of Alzheimer's disease.

  2017cites this paper
• Factores neuropsicológicos y genéticos asociados a la demencia incipiente desde el deterioro cogniti vo leve. Correlación fenotipo-genotipo

  2017cites this paper
• Apolipoprotein E Genotype and Sex Risk Factors for Alzheimer Disease: A Meta-analysis

  2017cites this paper
• Social Representation of Dementia: An Analysis of 5,792 Consecutive Cases Evaluated in a Memory Clinic

  2017cites this paper
• Natural cholinesterase inhibitors from Myristica cinnamomea King.

  2016cites this paper
• Beneficial Effects of an Integrated Psychostimulation Program in Patients with Alzheimer’s Disease

  2016cites this paper
• Memory Clinics and Care Management Programs

  2016cites this paper
• Influence of Sampling and Recruitment Methods in Studies of Subjective Cognitive Decline

  2015cites this paper
• Guidelines for dementia-related health advocacy for adults with intellectual disability and dementia: National Task Group on Intellectual Disabilities and Dementia Practices.

  2015cites this paper
• Potential hippocampal genes and pathways involved in Alzheimer's disease: a bioinformatic analysis.

  2015cites this paper
• Cut-off Scores of a Brief Neuropsychological Battery (NBACE) for Spanish Individual Adults Older than 44 Years Old

  2013cites this paper
• receptors sAXL and

  year unknowncites this paper